Arrowhead Pharmaceuticals (ARWR) Non Operating Investment Income (2011 - 2026)
Arrowhead Pharmaceuticals' Non Operating Investment Income came in at $19 million for fiscal Q2 2026 (quarter ended Mar 31, 2026).
Analysis
Arrowhead Pharmaceuticals (ARWR) Non Operating Investment Income (2011 - 2026) Analysis & Trends
For FY2015 (ended Sep 30, 2015), Arrowhead Pharmaceuticals' Non Operating Investment Income was $19,195.
- Non Operating Investment Income carries a five-year compound annual growth rate of 61.0% (FY2010 to FY2015).
- Going back by fiscal year, Non Operating Investment Income was -$58,878 in FY2014, -$76,388 in FY2013, -$1.08 million in FY2012 and -$261,219 in FY2011.
- The fiscal Q2 2026 figure represents the highest quarterly Non Operating Investment Income in data going back to fiscal Q2 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 9.06 Bn | 3.84 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 19.00 Mn |
| Mar 31, 2015 | 45,576.00 |
| Dec 31, 2014 | -26,381.00 |
| Mar 31, 2014 | -5,316.00 |
| Dec 31, 2013 | -53,562.00 |
| Jun 30, 2013 | -39,949.00 |
| Mar 31, 2013 | -54,932.00 |
| Dec 31, 2012 | 18,493.00 |
| Sep 30, 2012 | -169,616.00 |
| Jun 30, 2012 | -876,277.00 |
| Mar 31, 2012 | -33,484.00 |
| Dec 31, 2011 | -58,091.00 |
| Sep 30, 2011 | -122,733.00 |
| Jun 30, 2011 | -498,406.00 |
| Mar 31, 2011 | 359,920.00 |
API Access
Arrowhead Pharmaceuticals Non Operating Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ARWR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();